A database study on the expression of immune-related adverse events in immune checkpoint inhibitors in combination with chemotherapy for non-squamous cell carcinoma.

A database study on the expression of immune-related adverse events in immune checkpoint inhibitors in combination with chemotherapy for non-squamous cell carcinoma. - A database study on the expression of immune-related adverse events in immune checkpoint inhibitors in combination with chemotherapy for non-squamous cell carcinoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060118

Enrollment

100

Registered

2025-12-18

Start date

2025-12-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-squamous cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-squamous cell carcinoma and administration of targeted drugs

Exclusion criteria

Exclusion criteria: Patients with no covariates and no previous administration of the target drug

Design outcomes

Primary

Measure	Time frame
irAE rate	—

Secondary

Measure	Time frame
Calculation of descriptive statistics, etc.	—

Countries

Japan

Contacts

Public ContactKana Yamada

Chugai Pharmaceutical Co. Ltd Safety Science 2 Department

yamada.kana47@chugai-pharm.co.jp03-3281-6611

Outcome results